Author： Palma M. Adamson L. Hansson L. Kokhaei P. Rezvany R. Mellstedt H. Österborg A. Choudhury A.
Publisher： Springer Publishing Company
ISSN： 0340-7004
Source： Cancer Immunology, Immunotherapy, Vol.57, Iss.11, 2008-11, pp. : 1705-1710
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Alemtuzumab in chronic lymphocytic leukemia
By James Danelle F Kipps Thomas J
Future Oncology, Vol. 3, Iss. 1, 2007-02 ,pp. :
Access to resources
Recommend
By Andritsos Leslie Khoury Hanna
Current Treatment Options in Oncology, Vol. 3, Iss. 3, 2002-06 ,pp. :
B-cell receptor signaling in chronic lymphocytic leukemia leans on Lyn
Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. :
Realgar induces apoptosis in the chronic lymphocytic leukemia cell line MEC1
Molecular Medicine Reports, Vol. 8, Iss. 6, 2013-01 ,pp. :
BRAF mutations in chronic lymphocytic leukemia
By Jebaraj Billy Michael Chelliah
Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. :